STAAR SURGICAL CO (STAA)
STAAR SURGICAL CO (STAA) from its SEC filings: 2025 revenue $239.4 million (-24% vs the year before), net margin -34%, free cash flow -$40.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Ophthalmic Goods |
| Revenue (2025) | $239.4 million |
| Revenue growth | -24% |
| Net income | -$80.4 million |
| Net margin | -33.6% |
| Free cash flow | -$40.0 million |
| Diluted EPS | $-1.62 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +111% |
| Cash | $148.6 million |
| Share count, 1 year | +1% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.